OmniAb Correlations
OABIW Stock | USD 0.40 0.03 6.98% |
The current 90-days correlation between OmniAb Inc and Genfit is -0.16 (i.e., Good diversification). The correlation of OmniAb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
OmniAb |
Moving together with OmniAb Stock
0.76 | VALN | Valneva SE ADR | PairCorr |
0.74 | DVAX | Dynavax Technologies | PairCorr |
0.75 | VRNA | Verona Pharma PLC | PairCorr |
0.68 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against OmniAb Stock
0.81 | ME | 23Andme Holding | PairCorr |
0.71 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.69 | VCYT | Veracyte | PairCorr |
0.68 | VERA | Vera Therapeutics | PairCorr |
0.68 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.67 | VKTX | Viking Therapeutics | PairCorr |
0.64 | VCEL | Vericel Corp Ord | PairCorr |
0.61 | DNLI | Denali Therapeutics | PairCorr |
0.61 | DRTS | Alpha Tau Medical | PairCorr |
0.61 | SABSW | SAB Biotherapeutics | PairCorr |
0.54 | A | Agilent Technologies | PairCorr |
0.53 | CDIOW | Cardio Diagnostics | PairCorr |
0.36 | DSGN | Design Therapeutics Potential Growth | PairCorr |
0.33 | DRRX | Durect Earnings Call This Week | PairCorr |
0.76 | VTYX | Ventyx Biosciences | PairCorr |
0.75 | VYGR | Voyager Therapeutics | PairCorr |
0.72 | VRDN | Viridian Therapeutics | PairCorr |
0.71 | ELAN | Elanco Animal Health | PairCorr |
0.69 | VTRS | Viatris | PairCorr |
0.68 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.68 | ELEV | Elevation Oncology | PairCorr |
0.6 | VXRT | Vaxart Inc | PairCorr |
0.59 | VRAX | Virax Biolabs Group | PairCorr |
0.55 | DYAI | Dyadic International Earnings Call This Week | PairCorr |
0.48 | VYNE | Vyne Therapeutics | PairCorr |
0.37 | ELDN | Eledon Pharmaceuticals Earnings Call This Week | PairCorr |
0.35 | VRCA | Verrica Pharmaceuticals | PairCorr |
Related Correlations Analysis
0.11 | -0.36 | 0.67 | 0.49 | -0.52 | LPCN | ||
0.11 | 0.24 | 0.48 | 0.49 | -0.1 | GNFT | ||
-0.36 | 0.24 | -0.13 | 0.13 | -0.09 | ARDX | ||
0.67 | 0.48 | -0.13 | 0.5 | -0.57 | TARS | ||
0.49 | 0.49 | 0.13 | 0.5 | -0.45 | BNTX | ||
-0.52 | -0.1 | -0.09 | -0.57 | -0.45 | KDP | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OmniAb Stock performing well and OmniAb Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OmniAb's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LPCN | 3.13 | (0.46) | 0.00 | (0.62) | 0.00 | 5.26 | 21.22 | |||
GNFT | 2.51 | (0.15) | 0.00 | 0.19 | 0.00 | 6.43 | 15.06 | |||
ARDX | 3.15 | 0.25 | 0.05 | 0.08 | 4.21 | 8.32 | 27.51 | |||
TARS | 2.51 | (0.06) | 0.00 | (0.25) | 0.00 | 5.03 | 14.81 | |||
BNTX | 2.48 | (0.12) | 0.00 | (0.22) | 0.00 | 4.75 | 16.34 | |||
KDP | 1.09 | 0.03 | 0.08 | 0.09 | 1.35 | 2.18 | 6.15 |
OmniAb Corporate Management
Cia McCaffrey | Vice Talent | Profile | |
Donna CPA | Senior Controller | Profile | |
Yasmina Abdiche | Senior Research | Profile | |
Bill Harriman | Senior Discovery | Profile | |
Douglas Krafte | Senior Head | Profile | |
MarieCecile DVM | Senior Genetics | Profile |